These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 12885482)

  • 1. Survivin and molecular pathogenesis of colorectal cancer.
    Kim PJ; Plescia J; Clevers H; Fearon ER; Altieri DC
    Lancet; 2003 Jul; 362(9379):205-9. PubMed ID: 12885482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression.
    Ma H; Nguyen C; Lee KS; Kahn M
    Oncogene; 2005 May; 24(22):3619-31. PubMed ID: 15782138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Indomethacin induces apoptosis through inhibition of survivin regulated by beta-catenin/TCF4 in human colorectal cancer cells].
    Zhu HX; Zhang G; Wang YH; Zhou CQ; Bai JF; Xu NZ
    Ai Zheng; 2004 Jul; 23(7):737-41. PubMed ID: 15248904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cdx1 inhibits human colon cancer cell proliferation by reducing beta-catenin/T-cell factor transcriptional activity.
    Guo RJ; Huang E; Ezaki T; Patel N; Sinclair K; Wu J; Klein P; Suh ER; Lynch JP
    J Biol Chem; 2004 Aug; 279(35):36865-75. PubMed ID: 15215241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of multipotent stem cells during morphogenesis of small intestinal crypts of Lieberkuhn is perturbed by stimulation of Lef-1/beta-catenin signaling.
    Wong MH; Huelsken J; Birchmeier W; Gordon JI
    J Biol Chem; 2002 May; 277(18):15843-50. PubMed ID: 11854293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Casein kinase 2 (CK2) increases survivin expression via enhanced beta-catenin-T cell factor/lymphoid enhancer binding factor-dependent transcription.
    Tapia JC; Torres VA; Rodriguez DA; Leyton L; Quest AF
    Proc Natl Acad Sci U S A; 2006 Oct; 103(41):15079-84. PubMed ID: 17005722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indomethacin induces differential expression of beta-catenin, gamma-catenin and T-cell factor target genes in human colorectal cancer cells.
    Hawcroft G; D'Amico M; Albanese C; Markham AF; Pestell RG; Hull MA
    Carcinogenesis; 2002 Jan; 23(1):107-14. PubMed ID: 11756231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB.
    Batlle E; Henderson JT; Beghtel H; van den Born MM; Sancho E; Huls G; Meeldijk J; Robertson J; van de Wetering M; Pawson T; Clevers H
    Cell; 2002 Oct; 111(2):251-63. PubMed ID: 12408869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription.
    Torres VA; Tapia JC; Rodriguez DA; Lladser A; Arredondo C; Leyton L; Quest AF
    Mol Cell Biol; 2007 Nov; 27(21):7703-17. PubMed ID: 17785436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of BMP and activin membrane-bound inhibitor (BAMBI), an inhibitor of transforming growth factor-beta signaling, as a target of the beta-catenin pathway in colorectal tumor cells.
    Sekiya T; Adachi S; Kohu K; Yamada T; Higuchi O; Furukawa Y; Nakamura Y; Nakamura T; Tashiro K; Kuhara S; Ohwada S; Akiyama T
    J Biol Chem; 2004 Feb; 279(8):6840-6. PubMed ID: 14660579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the versican promoter by the beta-catenin-T-cell factor complex in vascular smooth muscle cells.
    Rahmani M; Read JT; Carthy JM; McDonald PC; Wong BW; Esfandiarei M; Si X; Luo Z; Luo H; Rennie PS; McManus BM
    J Biol Chem; 2005 Apr; 280(13):13019-28. PubMed ID: 15668231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of AKT1 expression by beta-catenin/Tcf/Lef signaling in colorectal cancer cells.
    Dihlmann S; Kloor M; Fallsehr C; von Knebel Doeberitz M
    Carcinogenesis; 2005 Sep; 26(9):1503-12. PubMed ID: 15888491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Id2 is a target of the beta-catenin/T cell factor pathway in colon carcinoma.
    Rockman SP; Currie SA; Ciavarella M; Vincan E; Dow C; Thomas RJ; Phillips WA
    J Biol Chem; 2001 Nov; 276(48):45113-9. PubMed ID: 11572874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celecoxib inhibits the expression of survivin via the suppression of promoter activity in human colon cancer cells.
    Sakoguchi-Okada N; Takahashi-Yanaga F; Fukada K; Shiraishi F; Taba Y; Miwa Y; Morimoto S; Iida M; Sasaguri T
    Biochem Pharmacol; 2007 May; 73(9):1318-29. PubMed ID: 17270149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells.
    Ghosh JC; Altieri DC
    Clin Cancer Res; 2005 Jun; 11(12):4580-8. PubMed ID: 15958644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression.
    Lee SC; Kim OH; Lee SK; Kim SJ
    Oncotarget; 2015 Sep; 6(29):27146-59. PubMed ID: 26450645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells.
    van de Wetering M; Sancho E; Verweij C; de Lau W; Oving I; Hurlstone A; van der Horn K; Batlle E; Coudreuse D; Haramis AP; Tjon-Pon-Fong M; Moerer P; van den Born M; Soete G; Pals S; Eilers M; Medema R; Clevers H
    Cell; 2002 Oct; 111(2):241-50. PubMed ID: 12408868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate beta-catenin/TCF-4 signaling.
    Dihlmann S; Siermann A; von Knebel Doeberitz M
    Oncogene; 2001 Feb; 20(5):645-53. PubMed ID: 11313997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caveolin-1-mediated suppression of cyclooxygenase-2 via a beta-catenin-Tcf/Lef-dependent transcriptional mechanism reduced prostaglandin E2 production and survivin expression.
    Rodriguez DA; Tapia JC; Fernandez JG; Torres VA; Muñoz N; Galleguillos D; Leyton L; Quest AF
    Mol Biol Cell; 2009 Apr; 20(8):2297-310. PubMed ID: 19244345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.
    Araki Y; Okamura S; Hussain SP; Nagashima M; He P; Shiseki M; Miura K; Harris CC
    Cancer Res; 2003 Feb; 63(3):728-34. PubMed ID: 12566320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.